NMD_Logo3_reg.jpg
NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2
20 juin 2023 07h00 HE | NMD Pharma
NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2 Results from the study establish, for the...
NMD_Logo3_reg.jpg
NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2
20 juin 2023 01h00 HE | NMD Pharma
NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2 Results from the study establish, for the...
NMD_Logo3_reg.jpg
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
08 juil. 2021 07h00 HE | NMD Pharma
PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...
NMD_Logo3_reg.jpg
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
08 juil. 2021 02h00 HE | NMD Pharma
PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...